New strategy to attack aggressive brain cancer shows promise
Time:2024-04-30 23:36:35 Source:entertainmentViews(143)
WASHINGTON (AP) — A new strategy to fight an extremely aggressive type of brain tumor showed promise in a pair of experiments with a handful of patients.
Scientists took patients’ own immune cells and turned them into “living drugs” able to recognize and attack glioblastoma. In the first-step tests, those cells shrank tumors at least temporarily, researchers reported Wednesday.
So-called CAR-T therapy already is used to fight blood-related cancers like leukemia but researchers have struggled to make it work for solid tumors. Now separate teams at Massachusetts General Hospital and the University of Pennsylvania are developing next-generation CAR-T versions designed to get past some of glioblastoma’s defenses.
“It’s very early days,” cautioned Penn’s Dr. Stephen Bagley, who led one of the studies. But “we’re optimistic that we’ve got something to build on here, a real foundation.”
Previous:Zambian bank hails Chinese investment contribution to economic development
Next:China's Top Political Advisory Body Holds Press Conference Ahead of Annual Session
You may also like
- China Coast Guard stops four Philippine individuals from intruding into Huangyan Island
- Barry Odom signs 5
- Trump says Arizona's abortion ban goes 'too far'
- Agent at Bad Bunny
- Update: China unveils Shenzhou
- International migrants were attracted to large urban counties last year, Census Bureau data shows
- New Jersey officials drop appeal of judge's order to redraw Democratic primary ballot
- A Supreme Court social media ruling could set new free speech standards
- Xi sends greetings to Malaysia's new king